Prioritize pharmacovigilance by developing strong ... from training dedicated teams to developing and managing multiple adverse event reporting channels. In the same sense that one may not be ...

All adverse events are considered unexpected ... to medically important events which allows for rapid reporting to sponsor Pharmacovigilance departments. Significant changes to safety information ...

The AI in pharmacovigilance market is expected to grow at a CAGR of 12–15% from 2023 to 2030, driven by the need to automate ...

In an era defined by rapid advancements in pharmaceuticals and healthcare, ensuring the safety and efficacy of drugs is paramount. The global pharmacovigilance and drug safety software market is ...

Adverse drug reactions (ADRs) remain a common clinical problem since they can mimic many diseases and cause significant morbidity and mortality. Judicious prescribing is important to minimize ...

In an era marked by unprecedented advancements in healthcare, pharmacovigilance and drug safety software emerge as indispensable tools in ensuring the safety and efficacy of pharmaceutical products.

Researchers from the University of Bern analyzed over 300,000 FDA reports and found semaglutide use was linked to a higher ...

DGCI rules already require manufacturers, importers, and marketers of pharmaceutical products in India to report adverse events involving ... The latest pharmacovigilance document aims to ...